Physician profile
Alya K Saqer
NPI 1568965861
$752.88
in general payments reported to CMS, 2019-2025
12 companies · $200 in 2025
The $200 reported for 2025 was more than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $154 · 2024: $400 · 2025: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $753.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $752.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $124.65 | 2023-2024 | Cardiomems, Amplatzer |
| Lilly USA, LLC | $124.49 | 2024-2025 | Jaypirca |
| Karyopharm Therapeutics INC. | $123.30 | 2024-2025 | Xpovio |
| Medtronic, INC. | $87.47 | 2023-2025 | Azure Xt Dr Mri Surescan, Concertotm, Micra |
| Abbvie INC. | $65.79 | 2024-2025 | |
| Janssen Biotech, INC. | $61.97 | 2024 | Talvey, Tecvayli, Darzalex |
| Edwards Lifesciences Corporation | $38.48 | 2023 | The Edwards Sapien 3 Valve With Alterra Adaptive Prestent System |
| Genzyme Corporation | $32.99 | 2024 | |
| Incyte Corporation | $25.84 | 2025 | Monjuvi |
| Inspire Medical Systems, INC. | $25.08 | 2023 | Inspire |
| Genmab U.S., INC. | $22.72 | 2024 | Epkinly |
| W. L. Gore & Associates, INC. | $20.10 | 2023 | Gore Cardioform Septal Occluder |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alya Saqer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.